Sana Biotechnology
Seattle, US · 8 known investors
Sana is a biotech company developing engineered cell medicines, including gene therapies for gene modification and delivery, cell replacement therapies using stem cell biology, and manufacturing solutions to improve patient access to these treatments.
Founders & leadership
SH
Steve HarrPresident and Chief Executive Officer
Investors · 8
American Family VenturesBoston · $250K – $10M
ARCH Venture PartnersChicago · $50K – $250M
F-Prime Capital PartnersCambridge · $3M – $10M
Flagship PioneeringCambridge · $500K – $10Mvia Geoffrey von Maltzahn · board
Innovating CapitalNew York · $10K – $3M
JDRF T1D FundBoston
Manta Ray VenturesLondon
OUP (Osage University Partners)Bala Cynwyd · $1M – $20M
In the news
- Sana Biotechnology (SANA) Is Up 18.1% After Removal From Key Russell Value Indexes - What's Changed - Simply Wall St Newssimplywall.st · 2026
- Sana Biotechnology Raises $69 Million Through Equity Offering - TipRanks.comtipranks.com · 2026
- Sana Raises $55M in Fundingfinsmes.com · 2024
- Sana Benefits raises $20 millioncoverager.com · 2021
- Sana Raises $20M in Series A Extension Fundingfinsmes.com · 2021